Učitavanje...
Drug and Solute Transporters in Mediating Resistance to Novel Therapeutics in Multiple Myeloma
[Image: see text] Multiple myeloma remains an incurable malignancy of plasma cells. Novel therapies, notably proteasome inhibitors and immunomodulatory drugs, have improved the survival of multiple myeloma patients; however, patients either present with, or develop resistance to, these therapies. Re...
Spremljeno u:
| Izdano u: | ACS Pharmacol Transl Sci |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American
Chemical Society
2021
|
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8204322/ https://ncbi.nlm.nih.gov/pubmed/34151200 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsptsci.1c00074 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|